can I still get pregnant?" This question touch
Unlike most peptides on the FDA's review schedule, GHK-Cu (copper peptide) has a split regulatory path: non-injectable routes are being removed from Category 1, while injectable routes are being removed from Category 2 and both are heading to Pharmacy Compounding Advisory Committee (PCAC) review before February 2027
People bring it up for issues like gut irritation, leaky gut conversations, or inflammatory bowel related models in research contexts
Individual results vary based on baseline metabolic health, lifestyle factors, and protocol adherence
The most significant results generally appear between weeks four and eight, when tissue remodeling, collagen synthesis, and vascular repair processes reach their peak